Related references
Note: Only part of the references are listed.Revisiting the physiology of nausea and vomiting-challenging the paradigm
Rita J. Wickham
SUPPORTIVE CARE IN CANCER (2020)
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study
So-Yeon Jeon et al.
CANCER RESEARCH AND TREATMENT (2019)
Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence
Luigi Celio et al.
BMC CANCER (2019)
Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysis
Karin Jordan et al.
SUPPORTIVE CARE IN CANCER (2018)
CINV: still troubling patients after all these years
Matti Aapro
SUPPORTIVE CARE IN CANCER (2018)
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Paul J. Hesketh et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01)
Michio Nakamura et al.
ONCOLOGIST (2017)
Nausea: a review of pathophysiology and therapeutics
Prashant Singh et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
F. Roila et al.
ANNALS OF ONCOLOGY (2016)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
Rudolph M. Navari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron
Yoshito Komatsu et al.
CANCER SCIENCE (2015)
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
Massimo Di Maio et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study
Hye Sook Han et al.
ONCOLOGIST (2015)
Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?
Terry L. Ng et al.
ONCOLOGIST (2015)
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Yolanda Escobar et al.
SUPPORTIVE CARE IN CANCER (2015)
Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience
Catalina Hernandez Torres et al.
SUPPORTIVE CARE IN CANCER (2015)
Nausea and the quest for the perfect anti-emetic
Paul L. R. Andrews et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study
Alexander Molassiotis et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
Naomi Mizukami et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients
Michelle C. Janelsins et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Nausea still the poor relation in antiemetic therapy? The impact on cancer patients' quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster
Carlo Pirri et al.
SUPPORTIVE CARE IN CANCER (2013)
Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy
Joseph A. Roscoe et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Communicating About Chemotherapy-Induced Nausea and Vomiting: A Comparison of Patient and Provider Perspectives
John M. Salsman et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial
Luigi Celio et al.
SUPPORTIVE CARE IN CANCER (2011)
Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study
Carlo Pirri et al.
SUPPORTIVE CARE IN CANCER (2011)
Review article: metoclopramide and tardive dyskinesia
A. S. Rao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre
A. Molassiotis et al.
SUPPORTIVE CARE IN CANCER (2008)
Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment
Brigitte Bloechl-Daum et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy
J Vardy et al.
BRITISH JOURNAL OF CANCER (2006)
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
A Ihbe-Heffinger et al.
ANNALS OF ONCOLOGY (2004)
Incidence of chemotherapy-induced nausea and emesis after modern antiemetics - Perception versus reality
SM Grunberg et al.
CANCER (2004)
Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall
AR Martin et al.
SUPPORTIVE CARE IN CANCER (2003)
Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control
FM Schnell
ONCOLOGIST (2003)
Share Paper
